These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8050)

  • 1. Inhibition of NADPH oxidation and related drug oxidation in liver microsomes by zinc.
    Chvapil M; Ludwig JC; Sipes IG; Misiorowski RL
    Biochem Pharmacol; 1976 Aug; 25(15):1787-91. PubMed ID: 8050
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of zinc on NADPH oxidation and monooxygenase activity in rat hepatic microsomes.
    Jeffery EH
    Mol Pharmacol; 1983 Mar; 23(2):467-73. PubMed ID: 6132332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of NADPH oxidation and oxidative metabolism of drugs in liver microsomes by zinc.
    Chvapil M; Sipes IG; Ludwig JC; Halladay SC
    Biochem Pharmacol; 1975 Apr; 24(8):917-9. PubMed ID: 235935
    [No Abstract]   [Full Text] [Related]  

  • 4. Ethanol and drug metabolism in mouse liver microsomes subsequent to lipid peroxidation-induced destruction of cytochrome P-450.
    Vatsis KP; Kowalchyk JA; Schulman MP
    Biochem Biophys Res Commun; 1974 Nov; 61(1):258-64. PubMed ID: 4155297
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of cytochrome P-450-dependent mixed function oxidation by ethanol.
    Hayashi N; Kamada T; Sato N; Kasahara A; Peterson JA
    Dig Dis Sci; 1985 Apr; 30(4):334-9. PubMed ID: 2983957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of multiple applications of heavy metal salts on NADPH-dependent lipid peroxidation].
    Kadiĭska M; Stoĭchev Ts; Serbinova E
    Eksp Med Morfol; 1984; 23(3):123-6. PubMed ID: 6519013
    [No Abstract]   [Full Text] [Related]  

  • 7. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
    Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
    Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the spectral intermediate at 440 nm formed during mixed function substrate oxidation.
    Illing HP; Kunke S; Netter KJ
    Biochem Pharmacol; 1974 Sep; 23(18):2603-16. PubMed ID: 4153422
    [No Abstract]   [Full Text] [Related]  

  • 9. [Microsomal oxidation system in the course of development and aging].
    Lemeshko VV
    Biokhimiia; 1980 Nov; 45(11):1964-9. PubMed ID: 6786371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of malathion on hepatic microsomal metabolism of the male mouse.
    Stevens JT
    Pharmacology; 1974; 11(6):330-5. PubMed ID: 4413070
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of a series of beta-adrenergic blocking drugs with rat hepatic microsomal monooxygenase.
    Facino RM; Lanzani R
    Pharmacol Res Commun; 1979 May; 11(5):433-45. PubMed ID: 39298
    [No Abstract]   [Full Text] [Related]  

  • 12. Polyamines as modulators of drug oxidation reactions catalyzed by cytochrome P-450 from liver microsomes.
    Dalet C; Andersson KK; Dalet-Beluche I; Bonfils C; Maurel P
    Biochem Pharmacol; 1983 Feb; 32(4):593-601. PubMed ID: 6830623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxylations of bile acids by reconstituted systems from rat liver microsomes.
    Björkhem I; Danielsson H; Wikvall K
    J Biol Chem; 1974 Oct; 249(20):6439-45. PubMed ID: 4153957
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunochemical study on the route of electron transfer from NADH and NADPH to cytochrome P-450 of liver microsomes.
    Noshiro M; Harada N; Omura T
    J Biochem; 1980 Nov; 88(5):1521-35. PubMed ID: 7462192
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytochrome b5 as electron donor to rabbit liver cytochrome P-450LM2 in reconstituted phospholipid vesicles.
    Ingelman-Sundberg M; Johansson I
    Biochem Biophys Res Commun; 1980 Nov; 97(2):582-6. PubMed ID: 6781498
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyridine nucleotide involvement in rat hepatic microsomal drug metabolism--I. Factors that influence NADPH kinetic estimations during mixed function oxidase reactions.
    Gourlay GK; Stock BH
    Biochem Pharmacol; 1978 Mar; 27(6):965-8. PubMed ID: 26354
    [No Abstract]   [Full Text] [Related]  

  • 17. The inhibitory effect of pyrazinamide on microsomal monooxygenase activities is related to the binding to reduced cytochrome P-450.
    Maffei Facino R; Carini M
    Pharmacol Res Commun; 1980 Jun; 12(6):523-37. PubMed ID: 7403228
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic calcium efflux during cytochrome P-450-dependent drug oxidations at the endoplasmic reticulum in intact liver.
    Sies H; Graf P; Estrela JM
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3358-62. PubMed ID: 6943544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between reduced nicotinamide adenine dinucleotide phosphate-dependent lipid peroxidation and drug hydroxylation in rat liver microsomes.
    Pederson TC; Aust SD
    Biochem Pharmacol; 1974 Sep; 23(17):2467-9. PubMed ID: 4154752
    [No Abstract]   [Full Text] [Related]  

  • 20. [Interaction of acrylates with the microsomal oxidation system in the rat liver].
    Kotlovskiĭ IuV; Bekerev VE; Bachmanova GI; Ivanov VV
    Vopr Med Khim; 1985; 31(6):74-7. PubMed ID: 4090391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.